• A 36-year-old woman, presenting with fever, pancytopenia, hepatosplenomegaly, and striking effacement of the bone marrow by true malignant histiocytes, was found to have no benefit from the systemic administration of cyclophosphamide, vincristine sulfate, doxorubicin, prednisone, and highdose methotrexate with calcium leucovorin rescue. Striking histologic and clinical Improvement was noted after the administration of two cycles of etoposide and amsacrine, each cycle consisting of 100 mg/sq m/day of each agent for five days. We believe that this therapy should be considered for future patients demonstrating aggressive presentations of malignant histiocytosis.
(Arch Intern Med 1985;145:742-743)
Abrams RA, Hanson G, Hansen R, Baumann MA, Anderson T. Malignant Histiocytosis Resistant to Anthracycline: Response to Intensive Treatment With Etoposide and Amsacrine. Arch Intern Med. 1985;145(4):742–743. doi:10.1001/archinte.1985.00360040176038
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: